GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » Cyclically Adjusted Book per Share

Assembly Biosciences (FRA:V7B) Cyclically Adjusted Book per Share : €68.19 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Assembly Biosciences's adjusted book value per share for the three months ended in Mar. 2024 was €5.470. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €68.19 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Assembly Biosciences's average Cyclically Adjusted Book Growth Rate was -8.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Assembly Biosciences was 56.60% per year. The lowest was -7.30% per year. And the median was 24.65% per year.

As of today (2024-06-21), Assembly Biosciences's current stock price is €14.60. Assembly Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €68.19. Assembly Biosciences's Cyclically Adjusted PB Ratio of today is 0.21.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Assembly Biosciences was 11.75. The lowest was 0.10. And the median was 0.28.


Assembly Biosciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Assembly Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assembly Biosciences Cyclically Adjusted Book per Share Chart

Assembly Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.72 75.61 73.81 77.08 65.54

Assembly Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.59 68.07 72.69 65.54 68.19

Competitive Comparison of Assembly Biosciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Assembly Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assembly Biosciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's Cyclically Adjusted PB Ratio falls into.



Assembly Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Assembly Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.47/131.7762*131.7762
=5.470

Current CPI (Mar. 2024) = 131.7762.

Assembly Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 38.288 100.560 50.174
201409 50.592 100.428 66.384
201412 53.412 99.070 71.045
201503 85.028 99.621 112.473
201506 81.398 100.684 106.535
201509 77.837 100.392 102.171
201512 75.937 99.792 100.275
201603 68.366 100.470 89.668
201606 62.349 101.688 80.797
201609 55.891 101.861 72.305
201612 52.687 101.863 68.159
201703 43.983 102.862 56.346
201706 34.779 103.349 44.345
201709 27.295 104.136 34.540
201712 56.959 104.011 72.164
201803 48.874 105.290 61.169
201806 44.398 106.317 55.030
201809 92.674 106.507 114.662
201812 87.152 105.998 108.347
201903 79.142 107.251 97.240
201906 72.344 108.070 88.214
201909 65.904 108.329 80.168
201912 90.629 108.420 110.153
202003 83.808 108.902 101.412
202006 86.760 108.767 105.113
202009 83.717 109.815 100.459
202012 69.741 109.897 83.626
202103 62.143 111.754 73.276
202106 52.735 114.631 60.622
202109 48.673 115.734 55.420
202112 37.282 117.630 41.766
202203 33.229 121.301 36.099
202206 29.101 125.017 30.674
202209 25.600 125.227 26.939
202212 19.152 125.222 20.154
202303 15.155 127.348 15.682
202306 11.604 128.729 11.879
202309 8.915 129.860 9.047
202312 6.874 129.419 6.999
202403 5.470 131.776 5.470

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Assembly Biosciences  (FRA:V7B) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Assembly Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=14.60/68.19
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Assembly Biosciences was 11.75. The lowest was 0.10. And the median was 0.28.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Assembly Biosciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Assembly Biosciences (FRA:V7B) Business Description

Industry
Traded in Other Exchanges
Address
331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.

Assembly Biosciences (FRA:V7B) Headlines

No Headlines